GRM Overseas Reports Modest Profitability in FY26 Amid Strong Revenue Growth KRRO Q1 2026 Earnings EPS Beat by 1005 as Biotech Advances Pipeline Prediction Market Investment Plans Continue Despite Regulatory Uncertainty